Firmness or Hardness at Subcutaneous Injection Spot Mega Study
Contents
Firmness or Hardness at Subcutaneous Injection Spot
Firmness or Hardness at Subcutaneous Injection Spot

Related

A
1 to 5 Rating
A
Symptoms
A
Factors
A
Outcomes

Tags

Hardness at Subcutaneous Injection Spot
Firmness
Firmness Or Hardness at Subcutaneous Injection Spot
Firmnes
Firmne

Treatments Causing Firmness or Hardness at Subcutaneous Injection Spot

User-reported treatments that exhibited the side effect of Firmness or Hardness at Subcutaneous Injection Spot

Treatment Percent of Reports
Leuprolide 19%

Below is the change in Firmness or Hardness at Subcutaneous Injection Spot seen after the predictor is higher than average.

Predictors
of
Below is the change in after the listed predictor is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change from the average seen after the predictor is higher than average.

Firmness or Hardness at Subcutaneous Injection Spot Info

Property Value
Variable Name Firmness Or Hardness at Subcutaneous Injection Spot
Aggregation Method MEAN
Analysis Performed At 2020-03-02
Duration of Action 24 hours
Maximum Allowed Value 5 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 0
Number of Measurements (including those generated by tagged, joined, or child variables) 0
Public true
Onset Delay 0 seconds
Unit 1 to 5 Rating
User Variables 0
Variable Category Symptoms
Variable ID 87295